SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-316082
Filing Date
2020-12-14
Accepted
2020-12-11 19:54:01
Documents
7
Period of Report
2020-12-31
Effectiveness Date
2020-12-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A d847937ddef14a.htm DEF 14A 986088
2 GRAPHIC g847937g01b88.jpg GRAPHIC 197680
3 GRAPHIC g847937g02f96.jpg GRAPHIC 174746
4 GRAPHIC g847937g14n45.jpg GRAPHIC 92830
5 GRAPHIC g847937g20m47.jpg GRAPHIC 108867
6 GRAPHIC g847937g40b45.jpg GRAPHIC 96574
7 GRAPHIC g847937g83t26.jpg GRAPHIC 26677
  Complete submission text file 0001193125-20-316082.txt   1934022
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36483 | Film No.: 201384799
SIC: 8071 Services-Medical Laboratories